TREA

88493576 - NAVITOR PHARMACEUTICALS

Follow

Information

  • Trademark
  • 88493576
  • Serial Number
    88493576
  • Filing Date
    June 28, 2019
    5 years ago
  • Transaction Date
    February 07, 2023
    a year ago
  • Status Date
    February 07, 2023
    a year ago
  • Location Date
    February 07, 2023
    a year ago
  • Status Code
    602
  • Current Location
    TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
    Employee Name
    CARROLL, DORITT
  • Attorney Docket Number
    142802-002
    Attorney Name
    Glenn A. Gundersen
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
NAVITOR PHARMACEUTICALS
Case File Statements
  • GS0051: pharmaceutical preparations and substances for the prevention, treatment and diagnosis of cancer, diabetes, and heart disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of neurodegenerative diseases, namely, Alzheimer's disease, Parkinson's disease, and Huntington's disease; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of immune disorders, namely, psoriasis, rheumatoid arthritis, lupus, Chron's disease, inflammatory bowel disease, and multiple sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of metabolic, endocrine, cardiovascular, oncological, gastrointestinal, musculoskeletal, mitochondrial, autoimmune, and neurological related diseases and disorders; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of rare genetic diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of Leigh's syndrome, Friedrich's ataxia, lymphangioleiomyomatosis (LAM) and tuberous sclerosis; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of obesity and obesity related diseases; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of age-related diseases; pharmaceutical preparations and substances for modulating the catabolic or anabolic response to nutrients; pharmaceutical preparations and substances for the prevention, treatment and diagnosis of any disease related to muscle wasting diseases and conditions, including, cachexia, sarcopenia and muscle wasting due to prolonged immobilization; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting caloric intake and absorption; pharmaceuticals, therapeutics and nutraceuticals for use as active ingredients in foods, namely, dietary supplements; pharmaceuticals, therapeutics and nutraceuticals for use as food additives for medical purposes, namely, amino acids; dietetic substances for medical purposes, namely, dietetic foods such as dietary beverage supplements adapted for medical use; nutritional additives for medical purposes, namely, amino acids; pharmaceutical preparations and substances for the modulation of appetite, namely, appetite suppressants and satiety inducers
Case File Event Statements
  • 2/7/2023 - a year ago
    25 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/7/2023 - a year ago
    24 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2
  • 2/7/2023 - a year ago
    23 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2
  • 7/26/2022 - 2 years ago
    22 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/26/2022 - 2 years ago
    21 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 7/26/2022 - 2 years ago
    20 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/22/2022 - 2 years ago
    19 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 12/1/2021 - 3 years ago
    18 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 5/31/2021 - 3 years ago
    17 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 10/29/2020 - 4 years ago
    16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Type: RCSC
  • 4/8/2020 - 4 years ago
    15 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/8/2020 - 4 years ago
    14 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/8/2020 - 4 years ago
    13 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/20/2020 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/19/2020 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/19/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/19/2019 - 5 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/19/2019 - 5 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/19/2019 - 5 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/18/2019 - 5 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/10/2019 - 5 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 7/9/2019 - 5 years ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/8/2019 - 5 years ago
    3 - ASSIGNED TO LIE Type: ALIE
  • 7/2/2019 - 5 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 7/2/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP